|
Market Closed -
Hong Kong S.E.
04:08:32 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 5.335 HKD | -0.84% |
|
-7.78% | +1.23% |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| 08-31 | Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio | CI |
| Market Cap | 7.26B 8.5B 1.08B 945M 893M 810M 1.52B 104B 1.52B 10.69B 4.13B 52.88B 4.07B 3.98B 170B | P/E 2026 * |
-15.7x | P/E 2027 * | 7.64x |
|---|---|---|---|---|---|
| Enterprise Value | 6.29B 7.36B 938M 818M 772M 701M 1.31B 90.01B 1.32B 9.25B 3.57B 45.76B 3.52B 3.45B 147B | EV / Sales 2026 * |
14.9x | EV / Sales 2027 * | 1.88x |
| Free-Float |
79.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | -0.84% | ||
| 1 week | -7.78% | ||
| Current month | -7.22% | ||
| 1 month | -0.93% | ||
| 3 months | +15.23% | ||
| 6 months | -26.41% | ||
| Current year | +1.23% |
| 1 week | 5.06 |  | 6.14 |
| 1 month | 5.06 | | 6.65 |
| Current year | 4.01 | | 10.41 |
| 1 year | 4.01 | | 10.41 |
| 3 years | 0.8 | | 13.15 |
| 5 years | 0.8 | | 13.15 |
| 10 years | 0.8 | | 19.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 2022-08-24 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 2023-01-17 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 2016-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 2022-08-24 |
Edward Hu
BRD | Director/Board Member | 63 | 2021-07-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/30/26 | Other | Chief Executive Officer | 331,000 | 0.0207% | ||
| 6/12/26 | Other | Chairman | 100,000 | 0.0062% | ||
| 6/3/26 | Other | Chief Executive Officer | 105,000 | 0.0066% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.84% | -7.78% | -38.54% | +166.75% | 1.08B | |
| -0.58% | +0.43% | +31.09% | -4.81% | 78.35B | |
| -2.55% | +6.99% | +505.27% | +47.92% | 61.52B | |
| -1.11% | +5.08% | -11.47% | -33.91% | 59.78B | |
| +0.14% | -1.20% | -11.64% | +24.21% | 46.53B | |
| -0.24% | +1.22% | +2.26% | +151.03% | 45.5B | |
| -1.62% | -0.76% | +49.85% | -14.92% | 31.84B | |
| -1.81% | +3.16% | +45.71% | +110.57% | 25.4B | |
| +0.47% | +3.26% | -0.77% | +142.41% | 21.43B | |
| +0.27% | +1.96% | +62.19% | +102.81% | 15.77B | |
| Average | -0.79% | +1.20% | +63.40% | +69.21% | 38.72B | |
| Weighted average by Cap. | -0.92% | +2.32% | +93.15% | +40.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 495M 63.14M 55.06M 51.99M 47.21M 88.45M 6.06B 88.82M 623M 240M 3.08B 237M 232M 9.91B | 1.72B 2.02B 257M 224M 212M 192M 360M 24.66B 361M 2.53B 978M 12.54B 965M 944M 40.34B |
| Net income | -384M -449M -57.23M -49.9M -47.12M -42.79M -80.17M -5.49B -80.51M -564M -218M -2.79B -215M -210M -8.98B | 680M 797M 102M 88.54M 83.6M 75.91M 142M 9.74B 143M 1B 386M 4.95B 381M 373M 15.94B |
| Net Debt | -978M -1.14B -146M -127M -120M -109M -204M -14B -205M -1.44B -555M -7.12B -548M -536M -22.9B | -4.02B -4.71B -600M -523M -494M -449M -841M -57.6B -844M -5.92B -2.28B -29.28B -2.25B -2.2B -94.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | HK$5.335 | -0.84% | 15,649,300 |
| 26-09-17 | HK$5.380 | +3.56% | 16,464,128 |
| 26-09-16 | HK$5.195 | -12.62% | 20,548,379 |
| 26-09-15 | HK$5.945 | -0.50% | 25,034,500 |
| 26-09-14 | HK$5.975 | +3.28% | 13,259,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
Select your edition
All financial news and data tailored to specific country editions
